These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 11223270)
41. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review. Fujii AM; Carillo M Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811 [TBL] [Abstract][Full Text] [Related]
42. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pandit PB; Dunn MS; Colucci EA Pediatrics; 1995 Jan; 95(1):32-6. PubMed ID: 7770305 [TBL] [Abstract][Full Text] [Related]
43. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130 [TBL] [Abstract][Full Text] [Related]
44. Proceedings of the 24th International Workshop on Surfactant Replacement. Workshop dedicated in memory of Bengt Robertson. Ljubljana, Slovenia June 4-6, 2009. Neonatology; 2009; 95(4):340-80. PubMed ID: 19757515 [No Abstract] [Full Text] [Related]
45. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants. Curstedt T; Johansson J Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705 [TBL] [Abstract][Full Text] [Related]
46. [The exogenous surfactant and its effect on the respiratory distress syndrome (RDS)]. Brabec R; Zoban P; Tomásová H Cesk Fysiol; 1996 Sep; 45(3):139-45. PubMed ID: 8974827 [TBL] [Abstract][Full Text] [Related]
47. The future of surfactant therapy for patients with acute lung injury - new requirements and new surfactants. Spragg RG Biol Neonate; 2002; 81 Suppl 1():20-4. PubMed ID: 12011562 [TBL] [Abstract][Full Text] [Related]
48. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Soll RF; Blanco F Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951 [TBL] [Abstract][Full Text] [Related]
49. Exogenous surfactant administration during the transport of premature infants. Riek KM Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930 [No Abstract] [Full Text] [Related]
50. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease]. Lubetzky R; Dolberg S Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346 [No Abstract] [Full Text] [Related]
54. Surfactant protein A and surfactant protein D in health and disease. Mason RJ; Greene K; Voelker DR Am J Physiol; 1998 Jul; 275(1):L1-13. PubMed ID: 9688929 [TBL] [Abstract][Full Text] [Related]
55. Effect of exogenous surfactant on total respiratory system compliance. Milner AD; Vyas H; Hopkin IE Arch Dis Child; 1984 Apr; 59(4):369-71. PubMed ID: 6372707 [TBL] [Abstract][Full Text] [Related]
56. Surfactant for the treatment of respiratory distress syndrome. Jobe A; Ikegami M Am Rev Respir Dis; 1987 Nov; 136(5):1256-75. PubMed ID: 3314618 [No Abstract] [Full Text] [Related]
58. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Chida S; Phelps DS; Cordle C; Soll R; Floros J; Taeusch HW Am Rev Respir Dis; 1988 Apr; 137(4):943-7. PubMed ID: 3355003 [TBL] [Abstract][Full Text] [Related]
59. Advances with surfactant. Turell DC Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091 [TBL] [Abstract][Full Text] [Related]
60. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment. Chida S; Phelps DS; Soll RF; Taeusch HW Pediatrics; 1991 Jul; 88(1):84-9. PubMed ID: 2057277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]